# HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

> **NCT00056758** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 18 (—)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** Autologous Dendritic Cell HIV Vaccination

## Key facts

- **NCT ID:** NCT00056758
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 18 (—)
- **Last updated:** 2007-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00056758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00056758, "HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00056758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*